Suboxone is one of the FDA approved drugs to treat opioid use disorder. Bill Lackey/Staff
Photo: Staff Writer
Photo: Staff Writer

$29M coming to Ohio to continue battling opioid crisis

The federal government released the second installment of State Opioid Response grants Thursday and Ohio will receive $29 million to fight the opioid epidemic.

Ohio received the first half of more than $55 million awarded through the SOR grants in 2018. 

These funds will be used to expand access to addiction treatment, especially medication-assisted treatment with appropriate social supports. The Ohio Department of Mental Health and Addiction Services will distribute the funds to county addiction and mental health boards. 

RELATED: Ohio rule change sparks debate about addiction treatment

The state has used some of its SOR money to host free training for medical professionals to obtain waivers so they can prescribe buprenorphine, one of the drugs in medication-assisted treatment. 

“There isn’t a community in Ohio that hasn’t been touched by the addiction crisis, and we are doing all we can to fight it,” Sen. Sherrod Brown, D-OH said. “This much-needed investment will expand access to medication-assisted treatment that so many Ohioans rely on to help them in their recovery.”

RELATED: Dayton cut overdose deaths in half and learned these lessons to prevent another crisis

Sen. Rob Portman, R-OH, noted that Ohio is making progress in combating overdose deaths with the help of expanded treatment options. 

“The State Opioid Response grant will help our state continue to lead efforts to prevent drug abuse, treat individuals who become addicted, and help people get on a path to long-term recovery,” he said. 

RELATED: Local overdose crisis response earns county national award

  

Thank you for reading the Journal-News and for supporting local journalism. Subscribers: log in for access to your daily ePaper and premium newsletters.

Thank you for supporting in-depth local journalism with your subscription to the Journal-News. Get more news when you want it with email newsletters just for subscribers. Sign up here.

X